Sex steroids and immunity

Psychoneuroimmunology, Two-Volume Set

Volumn 1, Issue , 2007, Pages 207-216

  Cutolo, Maurizio ^a   Calvia, Alessandro ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882535261     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088576-3/50013-7     Document Type: Chapter

References (66)

1. Bijlsma J.W.J., Straub R.H., Masi A.T., Lahita R.G., Cutolo M. Neuroendocrine immune mechanisms in rheumatic diseases. Trends Immunol 2002, 23:59-61.
2. Straub R., Cutolo M. Impact of the hypothalamicpituitary-adrenal/gonadal axes and the peripheral nervous system in rheumatoid arthritis: a systemic pathogenic view point. Arthritis Rheum 2001, 44:493-495.
3. Cutolo M. Gender and the rheumatic diseases: epidemiological evidence and possible biologic mechanisms. Ann Rheum Dis 2003, 62:3. (sp0005).
4. Cutolo M., Villaggio B., Craviotto C., Pizzorni C., Seriolo B., Sulli A. Sex hormones and rheumatoid arthritis. Autoimmun Rev 2002, 1:284-289.
5. Cutolo M., Straub R. Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease. Clin Exp Rheumatol 2000, 18:655-658.
6. Maestroni G., Sulli A., Pizzorni C., Villaggio B., Cutolo M. Melatonin in rheumatoid arthritis: a disease promoting and modulating hormone?. Clin Exp Rheumatol 2002, 20:872-873.
7. Cutolo M. Solar light effects on relapse/onset circannual/ circadian rhythms in rheumatoid arthritis. Clin Exp Rheumatol 2003, 21:148-150.
8. Cutolo M., Straub R.H., Masi A.T., Bijlsma J.W.J., Lahita R., Bradlow H.L. Altered neuroendocrine immune (NEI) networks in rheumatology. Ann NY Acad Sci 2002, 966:xiii.
9. Kawasaki T., Ushiyama T., Inoue K., Hukuda S. Effects of estrogen on interleukin-6 production in rheumatoid fibroblast-like synoviocytes. Clin Exp Rheumatol 2000, 18:743-745.
10. Li Z.G., Danis V.A., Brooks P.M. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 1993, 11:157-162.
11. Cutolo M., Villaggio B., Montagna P., Capellino S., Seriolo B., Straub R.H., et al. Synovial fluid estrogens in rheumatoid arthritis. Autoimmun Rev 2004, 3:193-198.
12. Bijlsma J.W.J., Straub R.H., Masi A.T., Lahita R.G., Cutolo M. Neuroendocrine immune mechanisms in rheumatic diseases. Trends Immunol 2002, 23:59-66.
13. Lahita R.G., Bradlow H.L., Ginzler E., Pang S., New M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987, 30:241-248.
14. Macdiarmid F., Wang D., Duncan L.G. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor á. Mol Cell Endocrinol 1994, 106:17-21.
15. Purohit A, Ghilchic M.W., Duncan L. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995, 80:3052-3058.
16. Le Bail J., Liagre B., Vergne P., Bertin P., Beneytout J., Habrioux G. Aromatase in synovial cells from postmenopausal women. Steroids 2001, 66:749-755.
17. Castagnetta L., Cutolo M., Granata O., Di Falco M., Bellavia V., Carruba G. Endocrine end-points in rheumatoid arthritis. Ann N Y Acad Sci 1999, 876:180-192.
18. Tengstrand B., Carlstrom K., Fellander-Tsai L., Hafstrom I. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current. J Rheumatol 2003, 30:2338-2343.
19. Folomeev M., Dougados M., Beaune J., Kouyoumdjian J.C., Nahoul K., Amor B., et al. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1992, 1:191-195.
20. Castagnetta L.A., Carruba G., Granata O.M., Miele M., Cutolo M., Straub R.H., et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2003, 30:2597-2605.
21. Weidler C., Harle P., Schedel J., Schmidt M., Scholmerich J., Straub R.H. Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrog. J Rheumatol 2004, 31:489-495.
22. Kanda N., Tsuchida T., Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lu erythematosus. Arthritis Rheum 1999, 42:328-337.
23. Lahita R.G., Bradlow H.L., Kunkel H.G., Fishman J. Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 1979, 22:1195-1198.
24. Cutolo M., Sulli A., Seriolo B., Accardo S., Masi A.T. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995, 13:217-226.
25. Cutolo M., Sulli A., Seriolo B., Villaggio B., Straub R.H. New roles for estrogens in rheumatoid arthritis. Clin Exp Rheumatol 2003, 21:687-690.
26. McMurray R.W., May W. Sex hormones and systemic lupus erythematosus: review and meta-analysis. Arthritis Rheum 2003, 48:2100-2110.
27. Cutolo M. Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2004, 31:419-421.
28. Kramer P.R., Kramer S.F., Guan G. 17 betaestradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 2004, 50:1967-1975.
29. Doria A., Cutolo M., Ghirardello A., Zampieri S., Vescovi F., Sulli A., et al. Hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum 2002, 47:202-209.
30. Doria A., Ghirardello A., Punzi L., Sulli A., Gambari P.F., Cutolo M., et al. Pregnancy, cytokines and disease activ-ity in systemic lupus erythematosus. Arthritis Rheum 2004, 15:989-995.
31. Sanchez-Guerrero J., Villegas A., Mendoza-Fuentes A., Romero-Diaz J., Moreno-Coutino G., Cravioto M.C. Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus. Am J Med 2001, 111:464-468.
32. Kinne R.W., Brauer R., Stuhlmuller B., Palombo-Kinne E., Burmester G.R. Macrophages in rheumatoid arthritis. Arthritis Res 2000, 2:189-202.
33. Ghisletti S., Meda C., Maggi A., Vegeto E. 17â-estradiol inhibits inflammatory gene expression by controlling NF-kB intracellular localization. Mol Cell Biol 2005, 25:2957-2968.
34. Cerillo G., Rees A., Manchanda N., et al. The estrogen receptor regulates NF-kappaB and AP-1 activity in a cell-specific manner. J Steroid Biochem Mol Biol 1998, 67:79-88.
35. Pelzer T., Schumann M., Neumann M., De Jager T., Stimpel M., Serfling E., et al. 17-â estradiol prevents programmed cell death in cardiac myocytes. Biochem Biophys Res Commun 2000, 268:192-200.
36. Ling S., Dai A., Williams M.R., Myles K., Dilley R.J., Komesaroff P.A., Sudhir K. Testosterone (T) enhances apoptosis-related damage in human vascular endothelial cells. Endocrinology 2002, 143:1119-1125.
37. Honma S., Shimodaira K., Shimizu Y., Tsuchiya N., Saito H., Yanaihara T., et al. The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells. Endocr J 2002, 49:371-377.
38. Macdiarmid F., Wang D., Duncan L.G. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor á. Mol Cell Endocrinol 1994, 106:17-21.
39. Purohit A., Ghilchic M.W., Duncan L. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995, 80:3052-3058.
40. Le Bail J., Liagre B., Vergne P., Bertin P., Beneytout J., Habrioux G. Aromatase in synovial cells from postmenopausal women. Steroids 2001, 66:749-757.
41. Cutolo M., Lahita R.G. Estrogens and arthritis. Rheum Dis Clin North Am 2005, 31:19-27.
42. Cutolo M., Capellino S., Montagna P., Ghiorzo P., Sulli A., Villaggio B. Hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line. Arthritis Res Ther 2005, 7:1124-1133.
43. Straub R.H., Buttgereit F., Cutolo M. Benefit of pregnancy in inflammatory arthritis. Ann Rheum Dis 2005, 64:801-803.
44. Marzi M., Vigano A., Trabattoni D., Villa M.L., Salvaggio A., Clerici E., Clerici M. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996, 106:127-133.
45. Munoz-Valle J.F., Vazquez-Del Mercado M., Garcia-Iglesias T., Orozco-Barocio G., Bernard-Medina G., Martinez-Bonilla G., Bastidas-Ramirez B.E., Navarro A.D, Bueno M., Martinez-Lopez E., Best-Aguilera C.R., Kamachi M, Armendariz-Borunda J. T (H) 1/T (H) 2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients. Clin Exp Immunol 2003, 131:377-384.
46. Opsjon S.L., Wether N.C., Tingslad S., Wiedswang G., Sunden A., Waager A., Austejuler R. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993, 169:397-404.
47. Elenkov I.J., Hoffmann J., Wilder R.L. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postPARTum period?. Mol Med Today 1997, 3:379-383.
48. Russel A.S., et al. Evidence for reduced Th1 function in normal pregnancy: a hypothesis for the remission of rheumatoid arthritis. J Rheumatol 1997, 24:1045-1050.
49. Kupfermine M.J., Peaceman A.M., Aderka D., Wallach D., Peyser M.R., Lessing J.B., Socol M.L. Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid. Am J Obstet Gynecol 1995, 173:900-905.
50. Branch D.W. Physiologic adaptation of pregnancy. Am J Reprod Immunol 1992, 28:120-122.
51. Lin H., Mosman T.R., Guilbert L., Tntipopipats S., Wegmann T.G. Synthesis of T helper-2-cytokines at the maternal-fetal interface. J Immunol 1993, 151:4562-4573.
52. Greig P.C., Herbert W.N., Robinette B.L., Teot L.A. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infectio. Am J Obstet Gynecol 1995, 173:1223-1227.
53. Ramirez F., Fowell D.J., Puklavec M., Simmonds S., Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 1996, 156:2406-2412.
54. Piccinni M.P., Giudizi M.G., Biagiotti R., Beloni L., Giannarini L., Sampognaro S., Parronchi P., Manetti R., Annunziato F., Livi C. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in est Th1 cell clones. J Immunol 1995, 155:128-133.
55. Cutolo M., Sulli A., Seriolo B., Accardo S., Masi A.T. Estrogens, the immune response and autoimmunity. Clin Exp. Rheumatol. 1995, 13:217-226.
56. Lahita R.G. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheum 1999, 11:352-356.
57. Llorente L., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Maillot M.C., Durand-Gasselin I., Fourrier B.M., Galanaud P., Emilie D. Spontaneous production of interleukin-10 by B-lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993, 4:421-427.
58. Houssiau F.A., Lefebvre C., Vanden Berghe M., et al. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995, 4:393-395.
59. Park Y.B., Lee S.K., Kim D.S., Lee J., Lee C.H., Song C.H. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 1998, 16:283-288.
60. Grondal G., Gunnarson I., Ronnelid J., et al. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 2000, 18:565-570.
61. Lauwerys B.R., Garot N., Renauld J.C., Houssiau F.A. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arthritis Rheum 2000, 43:1976-1981.
62. Horowitz D.A., Gray J.D., Behrendsen S.C., Kubin M., Rengaraju M., Ohtsuka K., Trinchieri G. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 1998, 41:838-844.
63. Liu T.F., Jones B.M. Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes. Cytokine 1998, 10:140-147.
64. Liu T.F., Jones B.M. Impairment of IL-12 production in SLE is due to defective monocytes, not B cells. Immuol Lett 1997, 56:314.
65. Houssiau F.A., Mascart-Lemone F., Stevens M., Libin M., Devogelaer J.P., Goldman M., Renauld J.C. IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC). Clin Exp Immunol 1997, 108:375-380.
66. Kovacs E.J., Messingham K.A., Gregory M.S. Estrogen regulation of immune responses after injury. Mol Cell Endocrinol 2002, 193:129-135.